2026年3月最新《新锐期刊分区表》数据已更新,欢迎查询使用。如果您对期刊系统有任何需求或者问题,欢迎反馈给我们。
![]() |
体验更多LetPub AI科研工具 >> | |
| 近期推荐: | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 新 聚合物期刊JPM征稿|IF持续上升 + APC折扣 | 热 Springer Nature特刊征稿 |
| |
| 基本信息 | 登录收藏 | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字![]() | Cancer Cell International CANCER CELL INT (此期刊被最新的JCR期刊SCIE收录) LetPub评分 6.7
88人评分
我要评分
声誉 7.2 影响力 6.0 速度 7.4 | |||||||||||||||||||||||||
| 期刊ISSN | 1475-2867 | 安装APP,查看期刊最新消息
| ||||||||||||||||||||||||
| 2024-2025最新影响因子 (数据来源于搜索引擎) | 6 点击查看影响因子趋势图 | |||||||||||||||||||||||||
| 实时影响因子 | 截止2026年5月06日:6.99 | |||||||||||||||||||||||||
| 2024-2025自引率 | 1.7%点击查看自引率趋势图 | |||||||||||||||||||||||||
| 五年影响因子 | 5.3 | |||||||||||||||||||||||||
| JCI期刊引文指标 | 1.08 | |||||||||||||||||||||||||
| h-index | 47 | |||||||||||||||||||||||||
| CiteScore ( 2025年最新版) |
| |||||||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||||||
| 期刊官方网站 | http://cancerci.biomedcentral.com | |||||||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||||||
| 期刊投稿网址 | https://submission.nature.com/new-submission/12935/3 | |||||||||||||||||||||||||
| 作者指南网址 | http://cancerci.biomedcentral.com/submission-guidelines | |||||||||||||||||||||||||
| 该期刊中国学者近期发文 - New | Retraction: Lnc-LRRTM4 promotes proliferation, metastasis and EMT of colorectal cancer through activating LRRTM4 transcription Author: Zhang, Jingjie; Meng, Xianmei; Zhou, Yi; Jiang, Zhengyu; Chen, Hongsuo; Meng, Zhiyi; Zhang, Qi; Chen, Weichang Journal: CANCER CELL INTERNATIONAL. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12935-026-04228-z Research on EBV-miR-BART17-5p targeted Inhibition of ARID1A expression to regulate nasopharyngeal carcinoma dedifferentiation Author: Wu, Zhen; Su, Xinxiang; Qin, Yaping; Pu, Junjun; Xiao, Shengjun; Zhang, Xiaoling Journal: CANCER CELL INTERNATIONAL. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12935-026-04207-4 Mechanism by which Icariin suppresses pulmonary metastasis in triple-negative breast cancer through downregulation of the SPDL1/JAK2/STAT3 signaling pathway Author: Xiao, Zengyou; Yang, Zean; Li, Xiaotong; Chen, Xin; Li, Jiaxian; He, Yujie; Li, Wei; Wang, Jie Journal: CANCER CELL INTERNATIONAL. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12935-026-04216-3 Spatial transcriptomics and single-cell analyses reveal the role of the cisplatin-resistant gene panel in NSCLC progression and the tumor microenvironment, identifying LOXL2 as a potential therapeutic target Author: Liu, Junzhi; Li, Huimin; Jiao, Yuheng; Hou, Meng Journal: CANCER CELL INTERNATIONAL. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12935-026-04170-0 | |||||||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Cancer Cell International的语言要求,还能让Cancer Cell International编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Cancer Cell International编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢(6篇) 。
提交文稿 | |||||||||||||||||||||||||
| 是否OA开放访问 | Yes | |||||||||||||||||||||||||
OA期刊相关信息![]() | 文章处理费:需要( GBP2190; USD2990; EUR2490; ) 文章处理费豁免:查看说明 其他费用:没有 期刊主题关键词:cancer cell biology、cell culture 相关链接:Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | |||||||||||||||||||||||||
| 通讯方式 | BIOMED CENTRAL LTD, 236 GRAYS INN RD, FLOOR 6, LONDON, ENGLAND, WC1X 8HL | |||||||||||||||||||||||||
| 出版商 | BioMed Central | |||||||||||||||||||||||||
| 涉及的研究方向 | ONCOLOGY- | |||||||||||||||||||||||||
| 出版国家或地区 | ENGLAND | |||||||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||||||
| 出版周期 | Irregular | |||||||||||||||||||||||||
| 出版年份 | 2001 | |||||||||||||||||||||||||
| 年文章数 | 406点击查看年文章数趋势图 | |||||||||||||||||||||||||
| Gold OA文章占比 | 99.91% | |||||||||||||||||||||||||
| 研究类文章占比: 文章 ÷(文章 + 综述) | 76.11% | |||||||||||||||||||||||||
| WOS期刊JCR分区 ( 2024-2025年最新版) | WOS分区等级:1区
| |||||||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版:不在预警名单中 2025年03月发布的2025版:不在预警名单中 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:预警等级:中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||||||
| 《新锐期刊分区表》 ( 2026年3月发布) | 点击查看期刊分区表趋势图
| |||||||||||||||||||||||||
| 期刊分区表 ( 2025年3月升级版) |
| |||||||||||||||||||||||||
| 期刊分区表 ( 2023年12月旧的升级版) |
| |||||||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1475-2867%5BISSN%5D | |||||||||||||||||||||||||
| 平均审稿速度 | 网友分享经验: 平均1月 | |||||||||||||||||||||||||
| 平均录用比例 | 网友分享经验: 约50% | |||||||||||||||||||||||||
| 版面费/APC文章处理费信息 | 文章处理费:需要( GBP2190; USD2990; EUR2490; ) 文章处理费豁免:查看说明 其他费用:没有 LetPub提供文章处理费(APC)支持服务,可以用人民币支付版面费啦! | |||||||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在Cancer Cell International顺利发表。
快看看作者怎么说吧:服务好评 论文致谢(6篇) 。 提交文稿 | |||||||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Retraction: Lnc-LRRTM4 promotes proliferation, metastasis and EMT of colorectal cancer through activating LRRTM4 transcription Author: Zhang, Jingjie; Meng, Xianmei; Zhou, Yi; Jiang, Zhengyu; Chen, Hongsuo; Meng, Zhiyi; Zhang, Qi; Chen, Weichang Journal: CANCER CELL INTERNATIONAL. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12935-026-04228-z PubMed DOI |
| 2. | Research on EBV-miR-BART17-5p targeted Inhibition of ARID1A expression to regulate nasopharyngeal carcinoma dedifferentiation Author: Wu, Zhen; Su, Xinxiang; Qin, Yaping; Pu, Junjun; Xiao, Shengjun; Zhang, Xiaoling Journal: CANCER CELL INTERNATIONAL. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12935-026-04207-4 PubMed DOI |
| 3. | Mechanism by which Icariin suppresses pulmonary metastasis in triple-negative breast cancer through downregulation of the SPDL1/JAK2/STAT3 signaling pathway Author: Xiao, Zengyou; Yang, Zean; Li, Xiaotong; Chen, Xin; Li, Jiaxian; He, Yujie; Li, Wei; Wang, Jie Journal: CANCER CELL INTERNATIONAL. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12935-026-04216-3 PubMed DOI |
| 4. | Spatial transcriptomics and single-cell analyses reveal the role of the cisplatin-resistant gene panel in NSCLC progression and the tumor microenvironment, identifying LOXL2 as a potential therapeutic target Author: Liu, Junzhi; Li, Huimin; Jiao, Yuheng; Hou, Meng Journal: CANCER CELL INTERNATIONAL. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12935-026-04170-0 PubMed DOI |
| 5. | Targeting ABCA3 impedes tumor progression and EGFR-TKI resistance in EGFR-mutant LUAD Author: Chen, Zhexian; Li, Guanting; Yang, Jianyuan; Chen, Zimo; Guo, Xu; Zhu, Liang; Zhou, Chao; Liu, Yuqing Journal: CANCER CELL INTERNATIONAL. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12935-026-04221-6 PubMed DOI |
| 6. | Beyond CRISPR: next-gen precision engineering of CAR-NK cells for enhanced persistence, trafficking, and tumor eradication Author: Dong, Aiyun; Soleimani Samarkhazan, Hamed; Tavakoli, Farzaneh Journal: CANCER CELL INTERNATIONAL. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12935-026-04219-0 PubMed DOI |
| 7. | Targeted suppression of DNA polymerase θ enhances calcium flux and triggers intrinsic apoptosis in gastric cancer Author: Wang, Yan; Nan, Junjun; Hu, Yangchan; Meng, Yuxin; Wang, Bing; Ye, Zu; Chu, Xiaohe; Jing, Ji; Cheng, Xiangdong Journal: CANCER CELL INTERNATIONAL. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12935-026-04206-5 PubMed DOI |
| 8. | VAMP7 governs ferroptosis suppression and cisplatin resistance in esophageal cancer: a dual-targeting therapeutic paradigm Author: Zhu, Jialiang; Xie, Minghua; Dai, Lei; Yang, Zhiming; Xue, Wenbo; Jiang, Zhibin; Zhou, Jingyue Journal: CANCER CELL INTERNATIONAL. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12935-025-04153-7 PubMed DOI |
| 9. | The molecular mechanism of IGF2BP3 promoting the malignant progression of lung cancer Author: Wu, Chenchen; Ma, Yufei; Li, Jiafan; Hai, Bohan; Zhou, Yueyang; Cao, Fei; Kang, Xiaohong; Xu, Xuelian Journal: CANCER CELL INTERNATIONAL. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12935-026-04217-2 PubMed DOI |
| 10. | Novel function of GTPBP2 in promoting hepatocellular carcinoma progression through inhibition of BTRC-mediated KRAS degradation Author: Huang, Po-Shuan; Chi, Hsiang-cheng; Lin, Yang-Hsiang; Huang, Wei-Chieh; Liao, Wan-Ting; Wang, Pei-Yun; Wang, Ling-Yu; Wang, Yi-Wen; Lin, Tzu-Kang; Liao, Chia-Jung; Chang, Che-Ju; Lay, Ing-Shiow; Yeh, Chau-Ting; Wang, Lu-Hai; Lin, Kwang-Huei Journal: CANCER CELL INTERNATIONAL. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12935-025-04029-w PubMed DOI |
|
|
|
投稿状态统计: 我要评分: | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范?试试稿件自查工具,一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验:共788条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号:沪ICP备10217908号-1
沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室